Bridging the Data Gap: Women’s Health Pioneer Evvy Secures $40M Series B to Scale Microbiome Diagnostics and AI-Driven Care
Executive Overview In a milestone development for the femtech and precision medicine sectors, women’s health diagnostics company Evvy announced on Tuesday that it has successfully closed a $40 million Series B funding round. The financing was led by Catalio Capital Management, a prominent investment firm focused on biomedical technology and innovative healthcare delivery. Founded in…
